Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Recent rulings of interest to you and your practice.
Features
e-Commerce entrepreneurs need many skills to succeed. First, they must have the technical chops to build and run a superior site. Next, they must market that site to stand out among the many competitors in a crowded market. They must also know enough about business to do all the above profitably. And since no one person can do all of these things well, nearly all of these entrepreneurs must be able to evaluate and hire people with all these skills. That is, until the day comes to sell the business ' the Holy Grail of the dot-com boom. Then, a whole new set of skills is required.
Features
A recent case of importance.
Features
Both commercial and residential tenants sometimes face the personal or economic need to leave leased premises before the expiration of the lease term. In times of economic recession, the problem is more serious ' both for landlords and for tenants ' than in boom times. What rights does a tenant have in this situation?
A guide to eerything contained in this issue, in an easy-to-use format.
The process of positioning lawyers and law firms for potential rankings ' all in an effort to boost their stature in a keenly competitive legal market, of course ' may impair the relationships with the very clients they hope to impress.
In 2009, the investments that so many had encouraged their respective firms to make actually started to pay some dividends.
<i>Cross-selling in today's environment? You must be kidding. I have enough trouble holding on to what I have.</i> If that's your reaction, it's understandable. After all, businesses are cutting back on expenses; and, as you well know, in-house legal departments are not immune.
Features
The Massachusetts Supreme Judicial Court ("SJC") has recognized a cause of action for the projected costs of medical monitoring when a product has not caused any actual disease or illness but solely subclinical physiological changes associated with an increased risk of disease. The decision will have broad implications for product manufacturers and sellers.
Features
On Sept. 30, 2009, the FDA issued a draft guidance for industry on better understanding and implementing Risk Evaluation and Mitigation Strategies (REMS), which the FDA requires for certain drugs or biologics.